I agree that this site is using cookies. You can find further informations here.
X
Zhou, Caicun
524  results:
Search for persons X
?
1

Anti-tumor efficacy of HRS-4642 and its potential combinati..:

Zhou, Caicun ; Li, Chongyang ; Luo, Libo...
Cancer Cell.  42 (2024)  7 - p. 1286-1300.e8 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Alectinib Versus Crizotinib in Asian Patients With Treatmen..:

Zhou, Caicun ; Lu, You ; Kim, Sang-We...
JTO Clinical and Research Reports.  5 (2024)  9 - p. 100700 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Publisher Correction: Interim survival analysis of the rand..:

Zhou, Caicun ; Wang, Ziping ; Sun, Meili...
Nature Cancer.  5 (2024)  1 - p. 209-209 , 2024
Link: https://doi.org/10.1038/..
 
?
4

Heterogeneity in advanced pulmonary sarcomatoid carcinoma a..:

Xie, Mengqing ; Chu, Tianqing ; Dong, Xiaorong...
European Journal of Cancer.  209 (2024)  - p. 114260 , 2024
Link: https://doi.org/10.1016/..
 
?
5

SIRPG expression positively associates with an inflamed tum..:

Luo, Libo ; Jiang, Minlin ; Wu, Hong...
Cancer Immunology, Immunotherapy.  73 (2024)  8 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
6

Plain language summary of PAPILLON: amivantamab plus chemot..:

Sabari, Joshua K ; Girard, Nicolas ; Mansfield, Aaron S...
Future Oncology.  , 2024
Link: https://doi.org/10.1080/..
 
?
7

First-line treatment with camrelizumab plus famitinib in ad..:

Ren, Shengxiang ; Wang, Xicheng ; Han, Bao-Hui...
Journal for ImmunoTherapy of Cancer.  12 (2024)  2 - p. e007227 , 2024
Link: https://doi.org/10.1136/..
 
?
8

Induction immunochemotherapy followed by definitive chemora..:

Wu, Leilei ; Cheng, Bo ; Sun, Xiaojiang...
MedComm.  5 (2024)  3 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
9

Identifying optimal ALK inhibitors in first- and second-lin..:

Zhao, Mingye ; Shao, Taihang ; Shao, Hanqiao..
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
10

Genomic correlates of the response to first-line PD-1 block..:

Jiang, Tao ; Chen, Jian ; Wang, Haowei...
Chinese Medical Journal.  , 2024
Link: https://doi.org/10.1097/..
 
?
11

NTRK gene fusion testing and management in lung cancer:

Repetto, Matteo ; Chiara Garassino, Marina ; Loong, Herbert H....
Cancer Treatment Reviews.  127 (2024)  - p. 102733 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Paclitaxel therapeutic drug monitoring - International asso..:

Hertz, Daniel L. ; Joerger, Markus ; Bang, Yung-Jue...
European Journal of Cancer.  202 (2024)  - p. 114024 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Osimertinib in combination with anti-angiogenesis therapy p..:

Han, Ruoshuang ; Guo, Haoyue ; Shi, Jinpeng...
BMC Medicine.  22 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
14

A Phase 1a/1b Dose Escalation/Expansion Study of the Anti-P..:

Gong, Jifang ; Guo, Ye ; Zhang, Yanqiao...
Targeted Oncology.  19 (2024)  5 - p. 723-733 , 2024
Link: https://doi.org/10.1007/..
 
?
15

PP01.24 FURVENT: Phase 3 trial testing furmonertinib vs che..:

Spira, Alexander ; Cho, Byoung Chul ; Felip, Enriqueta...
Journal of Thoracic Oncology.  19 (2024)  7 - p. e17-e18 , 2024
Link: https://doi.org/10.1016/..
 
1-15